DavidSBoyerMD
Ophthalmology • Los Angeles, CARetinal Disease, Uveitis, Ocular Oncology
Clinical Professor of Ophthalmology, USC School of Medicine
Dr. Boyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1245 Wilshire Blvd
Ste 380
Los Angeles, CA 90017Phone+1 213-483-8810Fax+1 213-481-1503- Is this information wrong?
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1976 - 1977
University of Southern California/LAC+USC Medical CenterResidency, Ophthalmology, 1973 - 1976- University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1972 - 1973
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2025
HI State Medical License Active through 2014
PA State Medical License 1976 - 1978- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Top MD Consumers Checkbook
- Join now to see all
Clinical Trials
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
- Seven Year Update of Macular Degeneration Patients Start of enrollment: 2010 Dec 01
- Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Suprachoroidal Space Injection Technique: Expert Panel Guidance.Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
- LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera...Boyer, D., Hu, A., Warrow, D., Xavier, S., Gonzalez, V., Lad, E., Rosen, R., Do, D., Schneiderman, T., Ho, A., Munk, M., Jaffe, G., Tedford, S., Croissant, C., Walker,...> ;Retina. 2024 Mar 1
- Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning.Giulia Corradetti, Nadav Rakocz, Jeffrey N Chiang, Oren Avram, Ahmed Roshdy Alagorie, Muneeswar Gupta Nittala, Ayesha Karamat, David S Boyer, David Sarraf, Eran Halper...> ;Eye. 2024 Apr 1
- Join now to see all
Press Mentions
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye DropsMay 22nd, 2023- Nanoscope Therapeutics Announces FDA Clearance of IND for MCO-010 Gene Therapy in Stargardt Macular Degeneration PatientsJanuary 25th, 2022
- Opthea Clinical Data of OPT-302 in Diabetic Macular Edema to Be Presented at American Society of Retina Specialists 2020 Annual MeetingJuly 23rd, 2020
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
Cedars-Sinai Medical CenterLos Angeles, California- PIH Health Good Samaritan HospitalLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
